CLS expands the product portfolio with new diffusing fiber for optimal thermal treatment of larger cancer tumors
Clinical Laserthermia Systems (CLS) (publ), has started the development of a new diffusing fiber, and will thereby expand the product portfolio with yet another fiber for treatment of cancer tumors, based on the same unique technology as the company’s existing TRANBERG® |Laser Applicator, none-cooled, diffuser. With the new fiber it will be possible to treat larger tumors and achieve an ablation size of up to about 40 millimeters. Like the existing diffusing fiber from CLS the new product can used for treatment with image guided laser ablation as well as for CLS’s proprietary imILT®